Nuveen Asset Management’s Organogenesis Holdings ORGO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.08M | Sell |
338,056
-436,307
| -56% | -$1.4M | ﹤0.01% | 2679 |
|
|
2024
Q3 | $2.21M | Buy |
774,363
+592,256
| +325% | +$1.69M | ﹤0.01% | 2366 |
|
|
2024
Q2 | $510K | Hold |
182,107
| – | – | ﹤0.01% | 2986 |
|
|
2024
Q1 | $517K | Hold |
182,107
| – | – | ﹤0.01% | 2964 |
|
|
2023
Q4 | $745K | Sell |
182,107
-52,890
| -23% | -$216K | ﹤0.01% | 2858 |
|
|
2023
Q3 | $747K | Buy |
234,997
+53,772
| +30% | +$171K | ﹤0.01% | 2691 |
|
|
2023
Q2 | $602K | Hold |
181,225
| – | – | ﹤0.01% | 2857 |
|
|
2023
Q1 | $386K | Sell |
181,225
-83,320
| -31% | -$177K | ﹤0.01% | 2867 |
|
|
2022
Q4 | $712K | Sell |
264,545
-120,302
| -31% | -$324K | ﹤0.01% | 2804 |
|
|
2022
Q3 | $1.25M | Sell |
384,847
-16,318
| -4% | -$52.9K | ﹤0.01% | 2647 |
|
|
2022
Q2 | $1.96M | Sell |
401,165
-486,136
| -55% | -$2.37M | ﹤0.01% | 2443 |
|
|
2022
Q1 | $6.69M | Sell |
887,301
-218,252
| -20% | -$1.65M | ﹤0.01% | 1902 |
|
|
2021
Q4 | $10.1M | Buy |
1,105,553
+81,588
| +8% | +$749K | ﹤0.01% | 1683 |
|
|
2021
Q3 | $17.1M | Buy |
1,023,965
+103,745
| +11% | +$1.73M | 0.01% | 1385 |
|
|
2021
Q2 | $15.3M | Sell |
920,220
-45,995
| -5% | -$764K | ﹤0.01% | 1577 |
|
|
2021
Q1 | $17.6M | Buy |
966,215
+884,258
| +1,079% | +$16.1M | 0.01% | 1423 |
|
|
2020
Q4 | $617K | Buy |
81,957
+35,474
| +76% | +$267K | ﹤0.01% | 2981 |
|
|
2020
Q3 | $178K | Buy |
46,483
+483
| +1% | +$1.85K | ﹤0.01% | 3172 |
|
|
2020
Q2 | $177K | Buy |
46,000
+19,740
| +75% | +$76K | ﹤0.01% | 3116 |
|
|
2020
Q1 | $85K | Sell |
26,260
-227
| -0.9% | -$735 | ﹤0.01% | 3076 |
|
|
2019
Q4 | $127K | Hold |
26,487
| – | – | ﹤0.01% | 3114 |
|
|
2019
Q3 | $174K | Hold |
26,487
| – | – | ﹤0.01% | 3132 |
|
|
2019
Q2 | $201K | Buy |
+26,487
| New | +$201K | ﹤0.01% | 3158 |
|